Outlook improves for AstraZeneca after profit rise

Second-quarter profits before tax at British biopharmaceutical firm AstraZeneca were at $2.40 billion, the company reported on Thursday, 15% higher than last year’s $2.09 billion. Earnings per share were $1.24, up 6% from last year’s $1.17. Core earnin…